Facebook
Twitter
Telegram
Report an ErrorAeglea BioTherapeutics Cash Flow 2011-2024 | AGLE
Annual Cash Flow Aeglea BioTherapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-99.9 M | -80.1 M | -53.7 M | -75.8 M | -65.7 M | -32.2 M | -24.6 M | -18.8 M | - | - | - | - | - |
Depreciation & Amortization |
744 K | 1.57 M | 1.58 M | 996 K | 418 K | 293 K | 249 K | 132 K | 89 K | 19 K | - | - | - |
Accounts Payables |
896 K | 677 K | 3.32 M | 2.25 M | 3.15 M | 663 K | 389 K | 168 K | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Aeglea BioTherapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-28.5 M | - | - | - | -17.6 M | - | -62 M | - | -26.3 M | - | -34.4 M | - | -19.5 M | - | -58.6 M | -41.1 M | -21.7 M | - | -49.4 M | -32.2 M | -15.8 M | - | -25 M | -16.5 M | -7.45 M | - | -18.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | - | - | 384 K | - | 1.18 M | - | 403 K | - | 1.16 M | - | 355 K | - | 627 K | 376 K | 154 K | - | 312 K | 207 K | 100 K | - | 221 K | 145 K | 70 K | - | 183 K | 114 K | 52 K | - | 96 K | 62 K | 29 K | - | 60 K | 35 K | 17 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
3.11 M | 896 K | 1.68 M | 2.85 M | 2.06 M | 677 K | 4.18 M | - | 2.98 M | 3.32 M | 1.86 M | 2.22 M | 1.88 M | 2.25 M | 2.25 M | 2.25 M | 2.25 M | 3.15 M | 3.15 M | 3.15 M | 3.15 M | 663 K | 663 K | 663 K | 663 K | 389 K | 389 K | 389 K | 389 K | 168 K | 168 K | 168 K | 168 K | 176 K | 176 K | 176 K | 176 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | 21.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency